Cargando…
Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma
Glioblastomas (GBM), deadly brain tumors, have greater incidence in males than females. Epidemiological evidence supports a tumor suppressive role of estrogen; however, estrogen as a potential therapy for GBM is limited due to safety concerns. Since GBM express ERβ, a second receptor for estrogen, t...
Autores principales: | Sareddy, Gangadhara R., Li, Xiaonan, Liu, Jinyou, Viswanadhapalli, Suryavathi, Garcia, Lauren, Gruslova, Aleksandra, Cavazos, David, Garcia, Mike, Strom, Anders M., Gustafsson, Jan-Ake, Tekmal, Rajeshwar Rao, Brenner, Andrew, Vadlamudi, Ratna K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850367/ https://www.ncbi.nlm.nih.gov/pubmed/27126081 http://dx.doi.org/10.1038/srep24185 |
Ejemplares similares
-
Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
por: Liu, Jinyou, et al.
Publicado: (2017) -
Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways
por: Zhou, Mei, et al.
Publicado: (2019) -
Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma
por: Pratap, Uday P, et al.
Publicado: (2021) -
Brain-Derived Estrogen and Neurological Disorders
por: Brann, Darrell W., et al.
Publicado: (2022) -
Neuron-Derived Estrogen—A Key Neuromodulator in Synaptic Function and Memory
por: Brann, Darrell W., et al.
Publicado: (2021)